Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Interest Coverage Ratio (2019 - 2025)

Kymera Therapeutics (KYMR) has disclosed Interest Coverage Ratio for 6 consecutive years, with 1064.09 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 22.26% to 1064.09 in Q4 2025 year-over-year; TTM through Dec 2025 was 944.32, a 10.13% increase, with the full-year FY2025 number at 944.32, up 10.13% from a year prior.
  • Interest Coverage Ratio was 1064.09 for Q4 2025 at Kymera Therapeutics, down from 944.08 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 371.38 in Q4 2023 to a low of 1402.66 in Q3 2023.
  • A 5-year average of 931.65 and a median of 902.31 in 2022 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: soared 43.28% in 2023, then tumbled 268.55% in 2024.
  • Kymera Therapeutics' Interest Coverage Ratio stood at 852.76 in 2021, then grew by 23.22% to 654.76 in 2022, then skyrocketed by 43.28% to 371.38 in 2023, then crashed by 268.55% to 1368.73 in 2024, then grew by 22.26% to 1064.09 in 2025.
  • Per Business Quant, the three most recent readings for KYMR's Interest Coverage Ratio are 1064.09 (Q4 2025), 944.08 (Q3 2025), and 782.94 (Q2 2025).